Literature DB >> 30327928

Percutaneous Cryotherapy for Treatment of Chondroblastoma: Early Experience.

Antoine Thibaut1, Amine Bouhamama2, Amélie Boespflug2, Gualter Vaz2, Marie Cuinet2, Anne-Charlotte Kalenderian2, Badis Menassel2, Alexis Ricoeur2, Charles Mastier2, Frank Pilleul2.   

Abstract

Surgical curettage is currently the standard of care for the chondroblastoma, but in peri-articular tumors it is limited by its morbidity. In this preliminary report, we evaluate the feasibility of percutaneous cryotherapy as an alternative ablative treatment for chondroblastoma. Three patients with a chondroblastoma treated by CT scan-guided cryotherapy are presented in this article. Pain permanently disappeared 2 days after the procedure. No local tumor recurrence or cartilage damage was observed by MRI performed 1 year after the intervention. This preliminary case report suggests that percutaneous cryotherapy may be a possible alternative to the current standard of care in chondroblastoma. Further studies are needed to evaluate if this technique offers similar anti-tumoral efficacy while providing better pain relief and less morbidity than curettage.

Entities:  

Keywords:  Benign bone tumor; Chondroblastoma; Cryotherapy; Percutaneous treatment

Mesh:

Year:  2018        PMID: 30327928     DOI: 10.1007/s00270-018-2085-y

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  3 in total

1.  Management of Juxta-articular chondroblastoma - Letter to editor.

Authors:  Karthikeyan P Iyengar; R Botchu
Journal:  J Clin Orthop Trauma       Date:  2022-08-12

2.  Have the difficulties and complications of surgical treatment for chondroblastoma of the adjoining knee joint been overestimated?

Authors:  Qing Liu; Hongbo He; Yuhao Yuan; Hao Zeng; Feng Long; Jian Tian; Wei Luo
Journal:  J Bone Oncol       Date:  2019-05-13       Impact factor: 4.072

3.  Chondroblastoma of the patella with pathological fracture in an adolescent: a case report.

Authors:  Yun Lang; Qing Yu; Yuehong Liu; Lejin Yang
Journal:  World J Surg Oncol       Date:  2019-12-12       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.